Insights

Strategic Expansion BioVectra's recent expansion into Nova Scotia and Prince Edward Island, including the opening of a 36,000 square-foot facility, indicates strong growth and increased capacity for biopharmaceutical manufacturing. This expansion presents opportunities to introduce new process development, manufacturing, and supply chain solutions to support their increased production needs.

Award-Winning Leadership Receiving the 2025 CDMO Leadership Award for biologics highlights BioVectra's recognized expertise and industry credibility. Engaging with their leadership team can open doors for collaborations on complex biologic projects, joint ventures, or supply agreements for advanced biopharmaceuticals.

Innovative Technologies BioVectra’s focus on biologics, mRNA, and potent APIs, along with their investment in biologics development, suggests a demand for advanced manufacturing technologies and process optimization solutions. Offering innovative equipment, automation, or bioanalytical services can address their focus on quality and innovation.

Financial Investment & Growth With revenues between $100 million and $1 billion and recent acquisition by H.I.G. Capital, BioVectra is in a growth phase with increasing capital investment. This environment offers opportunities to propose financing solutions, equipment leasing, or large-scale process development services to support their continued scale-up and innovation initiatives.

BIOVECTRA Tech Stack

BIOVECTRA uses 8 technology products and services including Fusion Ads, Blackline, Modernizr, and more. Explore BIOVECTRA's tech stack below.

  • Fusion Ads
    Advertising
  • Blackline
    Corporate Performance Management
  • Modernizr
    Javascript Libraries
  • Ceridian Payroll
    Payroll Management And Benefits Administration
  • Cloudflare Bot Management
    Security
  • Minitab
    Visualisation Software
  • Autoptimize
    Web Platform Extensions
  • Ivory Search
    Web Platform Extensions

Media & News

BIOVECTRA's Email Address Formats

BIOVECTRA uses at least 1 format(s):
BIOVECTRA Email FormatsExamplePercentage
FLast@biovectra.comJDoe@biovectra.com
97%
FiLast@biovectra.comJoDoe@biovectra.com
1%
FMiddleLast@biovectra.comJMichaelDoe@biovectra.com
1%
LFirst@biovectra.comDJohn@biovectra.com
1%

Frequently Asked Questions

Where is BIOVECTRA's headquarters located?

Minus sign iconPlus sign icon
BIOVECTRA's main headquarters is located at 11 Aviation Avenue, Charlottetown , PE C1e 0A1, CA. The company has employees across 2 continents, including North AmericaEurope.

What is BIOVECTRA's phone number?

Minus sign iconPlus sign icon
You can contact BIOVECTRA's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is BIOVECTRA's official website and social media links?

Minus sign iconPlus sign icon
BIOVECTRA's official website is biovectra.com and has social profiles on LinkedIn.

How much revenue does BIOVECTRA generate?

Minus sign iconPlus sign icon
As of October 2025, BIOVECTRA's annual revenue is estimated to be $20M.

What is BIOVECTRA's SIC code NAICS code?

Minus sign iconPlus sign icon
BIOVECTRA's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does BIOVECTRA have currently?

Minus sign iconPlus sign icon
As of October 2025, BIOVECTRA has approximately 603 employees across 2 continents, including North AmericaEurope. Key team members include Chief Operating Officer: T. D.Chief Commercial Officer: H. D.Vice President & General Manager, Biologics: S. D.. Explore BIOVECTRA's employee directory with LeadIQ.

What industry does BIOVECTRA belong to?

Minus sign iconPlus sign icon
BIOVECTRA operates in the Biotechnology Research industry.

What technology does BIOVECTRA use?

Minus sign iconPlus sign icon
BIOVECTRA's tech stack includes Fusion AdsBlacklineModernizrCeridian PayrollCloudflare Bot ManagementMinitabAutoptimizeIvory Search.

What is BIOVECTRA's email format?

Minus sign iconPlus sign icon
BIOVECTRA's email format typically follows the pattern of FLast@biovectra.com. Find more BIOVECTRA email formats with LeadIQ.

How much funding has BIOVECTRA raised to date?

Minus sign iconPlus sign icon
As of October 2025, BIOVECTRA has raised $40M in funding. The last funding round occurred on Mar 03, 2019 for $38M.

When was BIOVECTRA founded?

Minus sign iconPlus sign icon
BIOVECTRA was founded in 1970.
BIOVECTRA

BIOVECTRA

Biotechnology ResearchCanada501-1000 Employees

Expertise in both microbial fermentation and chemical synthesis allows us to tackle today’s development pipeline’s increasingly complex molecules. In fact, we thrive on the vexing challenges few CDMOs would have either the expertise or desire to address. Bold vision, along with the passion and commitment to make that vision a reality, is at the heart of our organization.

We are a forward-thinking, North American CDMO Pharmaceutical company  specializing in clinical-to-commercial scale production capabilities for:
Biologics
Synthetic small molecules 
Fermented small molecules
Highly potent APIs
Bioreagents
mRNA, pDNA, LNP manufacturing
Fill/Finish

Flexibility, creativity, and dedication to process optimization are at the heart of our method and process development as well as quality and compliance efforts. We ensure the programs advance on time and with the highest quality outcomes under our project managers’ leadership.

Section iconCompany Overview

Headquarters
11 Aviation Avenue, Charlottetown , PE C1e 0A1, CA
Phone number
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
1970
Employees
501-1000

Section iconFunding & Financials

  • $40M

    BIOVECTRA has raised a total of $40M of funding over 2 rounds. Their latest funding round was raised on Mar 03, 2019 in the amount of $38Mas a investment.

  • $50M$100M

    BIOVECTRA's revenue is estimated to be in the range of $50M$100M

Section iconFunding & Financials

  • $40M

    BIOVECTRA has raised a total of $40M of funding over 2 rounds. Their latest funding round was raised on Mar 03, 2019 in the amount of $38Mas a investment.

  • $50M$100M

    BIOVECTRA's revenue is estimated to be in the range of $50M$100M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.